دورية أكاديمية
Signs of dysregulated fibrinolysis precede the development of type 2 diabetes mellitus in a population-based study
| العنوان: | Signs of dysregulated fibrinolysis precede the development of type 2 diabetes mellitus in a population-based study |
|---|---|
| المؤلفون: | Hernestål-Boman Jenny, Norberg Margareta, Jansson Jan-Hakan, Eliasson Mats, Eriksson Jan W, Lindahl Bernt, Johansson Lars |
| المصدر: | Cardiovascular Diabetology, Vol 11, Iss 1, p 152 (2012) |
| بيانات النشر: | BMC |
| سنة النشر: | 2012 |
| المجموعة: | Directory of Open Access Journals: DOAJ Articles |
| مصطلحات موضوعية: | Diabetes mellitus type 2, Tissue plasminogen activator, Plasminogen activator inhibitor-1, Von Willebrand factor, Fibrinolysis, Population study, Västerbotten Intervention Programme, Diseases of the circulatory (Cardiovascular) system, RC666-701 |
| الوصف: | Background Diabetic patients experience stimulated coagulation and dysfibrinolysis, which is associated with an increased risk of cardiovascular events. This imbalance may precede the manifest diagnosis. We investigated whether elevated antigen levels of tissue plasminogen activator (tPA), plasminogen activator inhibitor-1 (PAI-1), the tPA/PAI-1 complex, or von Willebrand Factor (VWF) precede type 2 diabetes mellitus (T2DM) diagnosis, and whether this elevation occurs before increased fasting plasma glucose (FPG) or 2-hour plasma glucose (2hPG) in individuals who later develop T2DM. Methods We conducted a prospective incident case-referent study within the Västerbotten Intervention Programme. Cardiovascular risk factor data as well as FPG and 2hPG and blood samples for future research were collected at a baseline health examination between 1989 and 2000, (n= 28 736). During follow-up in January 2001, 157 cases had developed T2DM. Referents without T2DM were matched for sex, age, and year of participation (n=277). Subgroup analysis was performed for cases with normal baseline glucose levels (FPG <6.1 mmol/L and 2hPG < 8.9 mmol/L) and cases with elevated levels (FPG 6.1-6.9 mmol/L and/or 2hPG 8.9-12.1 mmol/L). Results After adjusting for BMI, family history of diabetes, physical activity, smoking, systolic blood pressure and levels of C-reactive protein and triglycerides, independent associations were found between incident T2DM and elevated levels of tPA (OR=1.54, 95% CI 1.06-2.23), PAI-1 (OR=1.61, 95% CI 1.14-2.28), and tPA/PAI-1 complex (OR=2.45, 95% CI 1.56-3.84). In participants with normal glucose levels, PAI-1 (OR=2.06, 95% CI 1.10 - 3.86) exhibited an independent relationship with incident T2DM after the adjustments. Conclusions Elevated levels of fibrinolytic variables precede the manifestation of T2DM after adjusting for metabolic and cardiovascular risk factors and can be detected several years before changes in glucose tolerance. |
| نوع الوثيقة: | article in journal/newspaper |
| اللغة: | English |
| تدمد: | 1475-2840 |
| العلاقة: | http://www.cardiab.com/content/11/1/152Test; https://doaj.org/toc/1475-2840Test; https://doaj.org/article/c85cb2169cba410da05fab56a0d6ed48Test |
| DOI: | 10.1186/1475-2840-11-152 |
| الإتاحة: | https://doi.org/10.1186/1475-2840-11-152Test https://doaj.org/article/c85cb2169cba410da05fab56a0d6ed48Test |
| رقم الانضمام: | edsbas.85B95A3E |
| قاعدة البيانات: | BASE |
Full Text Finder | تدمد: | 14752840 |
|---|---|
| DOI: | 10.1186/1475-2840-11-152 |